Endocyte, Inc. (ECYT) to Present at Upcoming Health Care and Investor Conferences  
8/29/2012 9:22:51 AM

WEST LAFAYETTE, Ind., Aug. 28, 2012 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that their company's management team will present at the following upcoming conferences: